A phase 2a randomized study to evaluate the safety and immunogenicity of the 1790GAHB GMMA vaccine against Shigella sonnei administered intramuscularly to adults from a shigellosis... by Obiero, C, Ndiaye, A, Scirè, A, Kaunyangi, B, Marchetti, E, Gone, A, Schütte, L, Riccucci, D, Auerbach, J, Saul, A, Martin, L, Bejon, P, Njuguna, P, Podda, A